Our Webinars

Our Webinars

Utilizing Inventive Biostatistical Methods to Enhance Rare Disease Trials

Utilizing Inventive Biostatistical Methods to Enhance Rare Disease Trials

Date: Monday, September 24, 2019
Time: 11am EDT(NA) / 4pm BST (UK) / 5pm CEST (EU-Central)
Length: 60 minutes

REGISTER

Every rare disease is a unique opportunity to create an impact on the health of others while simultaneously presenting us with unique challenges to deliver against that value and promise. Unfortunately, there is no panacea that we can take to make those challenges go away, therefore, we must approach each condition, each trial and each patient as the one-of-a-kind scenario they present. That doesn’t mean we approach this without methods and means to tackle these problems, but it does mean we often need to step outside of our comfort zone. There are myriad statistical methods available to us to minimize risk and maximize value but many of those methods are either unfamiliar or poorly understood outside of the biostatistician community.

In this free webinar, participants will be introduced to a variety of these statistical tools, learn about the kinds of impact they can provide and hear about some key questions/considerations that should be asked before starting a rare disease trial.

Presenter:

  • Walter Boyle, MS, Global Head of Biostatistics & Programming, Synteract


Looking for a previous webinar? Go to our Webinars Archive arrow
x

Submit RFI / RFP

..
By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Contact Synteract

Tell us how to stay in touch with you:

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Synteract General Medicince Clinical Trial Leadership

Linda RawlingsContact us to find out more about our General Medicine expertise and experience

Linda Rawlings, MSc, FIBMS
VP General Medicine

Contact us to find out more about our General Medicine expertise and experience
x

Synteract Rare and Orphan Diseases Clinical Trial Leadership

Lisa DilworthContact us to find out more about our Rare and Orphan Diseases expertise and experience

Lisa Dilworth
VP Rare and Orphan Diseases

Contact us to find out more about our Rare and Orphan Diseases expertise and experience
x

 

x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required

x

To complete your download, please choose an option in the Internet Explorer pop-up window at the bottom of this browser.

x

Opt In

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required